Association of history of cerebrovascular disease with severity of COVID-19.

Published on Mar 1, 2021in Journal of Neurology3.956
· DOI :10.1007/S00415-020-10121-0
Timo Siepmann17
Estimated H-index: 17
(TUD: Dresden University of Technology),
Timo Siepmann7
Estimated H-index: 7
(TUD: Dresden University of Technology)
+ 18 AuthorsKristian Barlinn21
Estimated H-index: 21
(TUD: Dresden University of Technology)
Sources
Abstract
To determine whether a history of cerebrovascular disease (CVD) increases risk of severe coronavirus disease 2019 (COVID-19). In a retrospective multicenter study, we retrieved individual data from in-patients treated March 1 to April 15, 2020 from COVID-19 registries of three hospitals in Saxony, Germany. We also performed a systematic review and meta-analysis following PRISMA recommendations using PubMed, EMBASE, Cochrane Library databases and bibliographies of identified papers (last search on April 11, 2020) and pooled data with those deriving from our multicenter study. Of 3762 records identified, 11 eligible observational studies of laboratory-confirmed COVID-19 patients were included in quantitative data synthesis. Risk ratios (RR) of severe COVID-19 according to history of CVD were pooled using DerSimonian and Laird random effects model. Between-study heterogeneity was assessed using Cochran’s Q and I2-statistics. Severity of COVID-19 according to definitions applied in included studies was the main outcome. Sensitivity analyses were conducted for clusters of studies with equal definitions of severity. Pooled analysis included data from 1906 laboratory-confirmed COVID-19 patients (43.9% females, median age ranging from 39 to 76 years). Patients with previous CVD had higher risk of severe COVID-19 than those without [RR 2.07, 95% confidence interval (CI) 1.52–2.81; p < 0.0001]. This association was also observed in clusters of studies that defined severe manifestation of the disease by clinical parameters (RR 1.44, 95% CI 1.22–1.71; p < 0.0001), necessity of intensive care (RR 2.79, 95% CI 1.83–4.24; p < 0.0001) and in-hospital death (RR 2.18, 95% CI 1.75–2.7; p < 0.0001). A history of CVD might constitute an important risk factor of unfavorable clinical course of COVID-19  suggesting a need of tailored infection prevention and clinical management strategies for this population at risk.
Figures & Tables
Download
📖 Papers frequently viewed together
10 Authors (Ma C, ..., Xian-xian Zhao)
126 Citations
2 Authors (Ya Gao, ..., Jinhui Tian)
3 Citations
46 Citations
References30
Newest
#1Jianlei Cao (WHU: Wuhan University)H-Index: 6
#2Wen Jun Tu (Peking Union Medical College)H-Index: 3
Last. Qiang Liu (Peking Union Medical College)H-Index: 6
view all 7 authors...
Objective In December, 2019, a series of pneumonia cases of unknown cause emerged in Wuhan, Hubei, China. In this study, we investigate clinical and laboratory features and short-term outcomes of patients with Corona Virus Disease 2019(COVID-19). Methods All patients with COVID-19 admitted to Wuhan University Zhongnan Hospital in Wuhan, China, between January 3 and February 1, 2020 were included. All those patients were with laboratory-confirmed infection. Epidemiological, clinical, radiological...
256 CitationsSource
#1Mohammad Madjid (University of Texas Health Science Center at Houston)H-Index: 32
#2Payam Safavi-Naeini (The Texas Heart Institute)H-Index: 6
Last. Orly Vardeny (UMN: University of Minnesota)H-Index: 26
view all 4 authors...
Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system. Observations Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications. A large proportion of patients have ...
809 CitationsSource
#1Tao Guo (WHU: Wuhan University)H-Index: 4
#2Yongzhen Fan (WHU: Wuhan University)H-Index: 4
Last. Zhibing Lu (WHU: Wuhan University)H-Index: 19
view all 10 authors...
Importance Increasing numbers of confirmed cases and mortality rates of coronavirus disease 2019 (COVID-19) are occurring in several countries and continents. Information regarding the impact of cardiovascular complication on fatal outcome is scarce. Objective To evaluate the association of underlying cardiovascular disease (CVD) and myocardial injury with fatal outcomes in patients with COVID-19. Design, Setting, and Participants This retrospective single-center case series analyzed patients wi...
1,750 CitationsSource
Rationale: COVID-19 pandemic is now a global health concern. Objectives: We compared the clinical characteristics, laboratory examinations, CT images and treatment of COVID-19 patients from three d...
411 CitationsSource
#1Elissa Driggin (NewYork–Presbyterian Hospital)H-Index: 3
#2Mahesh V. Madhavan (NewYork–Presbyterian Hospital)H-Index: 5
Last. Sahil A. Parikh (NewYork–Presbyterian Hospital)H-Index: 24
view all 16 authors...
Abstract The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and preexisting cardiovascular disease (CVD) have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias and veno...
886 CitationsSource
#1Xiaobo Yang (HUST: Huazhong University of Science and Technology)H-Index: 7
#2Yuan Yu (HUST: Huazhong University of Science and Technology)H-Index: 8
Last. You Shang (HUST: Huazhong University of Science and Technology)H-Index: 20
view all 16 authors...
Summary Background An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia. Methods In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who w...
4,791 CitationsSource
#1Alex John London (CMU: Carnegie Mellon University)H-Index: 27
#2Jonathan Kimmelman (McGill University)H-Index: 31
147 CitationsSource
#1Shaoqing Lei (WHU: Wuhan University)H-Index: 24
#2Fang Jiang (HKU: University of Hong Kong)H-Index: 2
Last. Zhengyuan Xia (HKU: University of Hong Kong)H-Index: 42
view all 12 authors...
Abstract Background The outbreak of 2019 novel coronavirus disease (COVID-19) in Wuhan, China, has spread rapidly worldwide. In the early stage, we encountered a small but meaningful number of patients who were unintentionally scheduled for elective surgeries during the incubation period of COVID-19. We intended to describe their clinical characteristics and outcomes. Methods We retrospectively analyzed the clinical data of 34 patients underwent elective surgeries during the incubation period of...
693 CitationsSource
#1Fei Zhou (Peking Union Medical College)H-Index: 5
#1Fei Zhou (Peking Union Medical College)H-Index: 7
Last. Bin CaoH-Index: 21
view all 19 authors...
BackgroundSince December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.
12.4k CitationsSource
#1Tao Chen (HUST: Huazhong University of Science and Technology)H-Index: 78
#1Tao Chen (HUST: Huazhong University of Science and Technology)H-Index: 6
Last. Qin Ning (HUST: Huazhong University of Science and Technology)H-Index: 25
view all 21 authors...
Objective To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. Design Retrospective case series. Setting Tongji Hospital in Wuhan, China. Participants Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. Data were collected until 28 February 2020. Main outcome measures Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection form...
1,947 CitationsSource
Cited By4
Newest
#1Yang Bai (Third Military Medical University)
#1Yang BaiH-Index: 1
view all 11 authors...
Background: Data on patients with coronavirus disease 2019 (COVID-19) who have pre-existing cerebrovascular disease (CVD) are scarce. This study set out to describe the clinical course and outcomes of these patients. Methods: This single-center retrospective study was performed at Huoshenshan Hospital in Wuhan, China. Patients with confirmed COVID-19 who had pre-existing CVD (N=69) were identified. COVID-19 patients without CVD were randomly selected and matched by age and sex to the patients wi...
Source
#1Saad AlhumaidH-Index: 5
#2Abbas Al Mutair (Princess Nora bint Abdul Rahman University)H-Index: 1
Last. Awad Al-Omari (Alfaisal University)H-Index: 17
view all 23 authors...
BACKGROUND: COVID-19 is a worldwide pandemic and has placed significant demand for acute and critical care services on hospitals in many countries. OBJECTIVES: To determine the predictors of severe COVID-19 disease requiring admission to an ICU by comparing patients who were ICU admitted to non-ICU groups. METHODS: A cohort study was conducted for the laboratory-confirmed COVID-19 patients who were admitted to six Saudi Ministry of Health's hospitals in Alahsa, between March 1, 2020, and July 30...
4 CitationsSource
COVID-19 infections have spread quickly, resulting in massive healthcare burden to societies worldwide. The most urgent interventions needed in the present climate include epidemiological measures to reduce the spread of infection, efficient treatment of patients with severe illness to reduce mortality rates, as well as development of diagnostic tests. Alongside this, the acute, medium, and long-term mental-health consequences of the COVID-19 outbreak for patients, their family members, medical ...
12 CitationsSource
#1Georgios Tsivgoulis (UoA: National and Kapodistrian University of Athens)H-Index: 31
#1Georgios Tsivgoulis (UTHSC: University of Tennessee Health Science Center)H-Index: 40
Last. Sotirios Tsiodras (UoA: National and Kapodistrian University of Athens)H-Index: 53
view all 16 authors...
Neurological manifestations are not uncommon during infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A clear association has been reported between cerebrovascular disease and coronavirus disease 2019 (COVID-19). However, whether this association is causal or incidental is still unknown. In this narrative review, we sought to present the possible pathophysiological mechanisms linking COVID-19 and cerebrovascular disease, describe the stroke syndromes and thei...
16 CitationsSource